How digital healthcare is leading the fight against COVID-19 for vulnerable people with Type 1 diabetes
Erik Bjorkman, General Manager EMEA at Dexcom, explains how Continuous Glucose Monitoring (CGM) is helping doctors remotely treat their patients with Type 1 diabetes during COVID-19, through its bluetooth technology and data sharing functions.
It’s no question the pandemic has had a huge impact on healthcare systems around the world. This has shone a light on the desperate need for a digital health transformation to ease the catastrophic strain and burden on the system and has prompted an increased demand for innovations. This is particularly true for healthcare systems across Europe where, in many cases, technology adoption has been slow.
In the high-risk group of individuals who live with Type 1 diabetes, there are many who rely on the Dexcom G6 Continuous Glucose Monitoring System every day to provide peace of mind around their diabetes management.
With a large number of people who live with Type 1 diabetes requiring regular check-ups, the Dexcom G6 allows healthcare providers to review a patient’s detailed glucose data remotely during telehealth appointments, helping to protect patients and medical staff from potential exposure to the virus while allowing for best-in-class care.
One of our core missions is to empower the patient to take control of their diabetes management. With the increased demand from Health Services across Europe for connected technology that helps free-up valuable clinician time, we recognised the need for our technology is now more critical than ever.
Digital innovations will continue to prove vital as we support patients both fighting the virus and those who are trying to stay safe and healthy during this unprecedented time. Remote monitoring technology, like CGM, is helping to alleviate pressure on the hospitals and key health workers, as well as keep patients safe, both during the crisis and in the aftermath as our healthcare systems recover.
Erik Bjorkman, General Manager EMEA at Dexcom